Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

GSK plc

GSKNYSE
Healthcare
Drug Manufacturers - General
$53.39
$-0.89(-1.64%)
U.S. Market opens in 0h 43m

GSK plc (GSK) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap107B
P/E Ratio14.31
EPS (TTM)$3.73
ROE0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$51.13
3 Months$71.27
1 Year Target$52.87

GSK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GSK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $52.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.31 and a market capitalization of 107B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.64%
5-Day Change
-1.87%
1-Month Change
-9.40%
3-Month Change
9.38%
6-Month Change
30.76%
Year-to-Date (YTD) Change
7.58%
1-Year Change
36.09%
3-Year Change
59.28%
5-Year Change
48.80%
All-Time (Max) Change
8035.62%

Contact Information

44 20 8047 5000
980 Great West Road, Brentford, NaN, TW8 9GS

Company Facts

686,290 Employees
IPO DateMar 28, 1980
CountryGB
Actively Trading

Frequently Asked Questions